Potent human monoclonal antibodies targeting Epstein-Barr virus gp42 reveal vulnerable sites for virus infection.
Zhao GX, Fang XY, Bu GL, Chen SJ, Sun C, Li T, Xie C, Wang Y, Li SX, Meng N, Feng GK, Zhong Q, Kong XW, Liu Z, Zeng MS.
Zhao GX, et al. Among authors: wang y.
Cell Rep Med. 2024 May 21;5(5):101573. doi: 10.1016/j.xcrm.2024.101573.
Cell Rep Med. 2024.
PMID: 38776874
Free PMC article.